Previous close | 1.1000 |
Open | 0.9000 |
Bid | 0.7500 |
Ask | 1.7000 |
Strike | 15.00 |
Expiry date | 2024-09-20 |
Day's range | 0.9000 - 1.1000 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Akoya (AKYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.